Global Testosterone Undecanoate Market Growth 2025-2031

October 2025 | 87 pages | ID: G5E200F0C2E1EN
LP Information

Abstracts

The global Testosterone Undecanoate market size is predicted to grow from US$ 631 million in 2025 to US$ 912 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.

United States market for Testosterone Undecanoate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Testosterone Undecanoate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Testosterone Undecanoate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Testosterone Undecanoate players cover Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Testosterone Undecanoate Industry Forecast? looks at past sales and reviews total world Testosterone Undecanoate sales in 2024, providing a comprehensive analysis by region and market sector of projected Testosterone Undecanoate sales for 2025 through 2031. With Testosterone Undecanoate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Testosterone Undecanoate industry.

This Insight Report provides a comprehensive analysis of the global Testosterone Undecanoate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Testosterone Undecanoate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Testosterone Undecanoate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Testosterone Undecanoate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Testosterone Undecanoate.

This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Undecanoate market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Injection
• Oral

Segmentation by Application:

• Primary Hypogonadism
• Hypogonadotropic Hypogonadism
• Late-Onset Hypogonadism

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bayer AG
• Endo Pharmaceuticals
• Merck Sharp & Dohme
• Taro Pharmaceutical
• Cipla
• Zhejiang Xianju Pharmaceutical
• Zhejiang Medicine Co.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Testosterone Undecanoate market?
What factors are driving Testosterone Undecanoate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Testosterone Undecanoate market opportunities vary by end market size?
How does Testosterone Undecanoate break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Testosterone Undecanoate Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Testosterone Undecanoate by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Testosterone Undecanoate by Country/Region, 2020, 2024 & 2031
2.2 Testosterone Undecanoate Segment by Type
  2.2.1 Injection
  2.2.2 Oral
2.3 Testosterone Undecanoate Sales by Type
  2.3.1 Global Testosterone Undecanoate Sales Market Share by Type (2020-2025)
  2.3.2 Global Testosterone Undecanoate Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Testosterone Undecanoate Sale Price by Type (2020-2025)
2.4 Testosterone Undecanoate Segment by Application
  2.4.1 Primary Hypogonadism
  2.4.2 Hypogonadotropic Hypogonadism
  2.4.3 Late-Onset Hypogonadism
2.5 Testosterone Undecanoate Sales by Application
  2.5.1 Global Testosterone Undecanoate Sale Market Share by Application (2020-2025)
  2.5.2 Global Testosterone Undecanoate Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Testosterone Undecanoate Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Testosterone Undecanoate Breakdown Data by Company
  3.1.1 Global Testosterone Undecanoate Annual Sales by Company (2020-2025)
  3.1.2 Global Testosterone Undecanoate Sales Market Share by Company (2020-2025)
3.2 Global Testosterone Undecanoate Annual Revenue by Company (2020-2025)
  3.2.1 Global Testosterone Undecanoate Revenue by Company (2020-2025)
  3.2.2 Global Testosterone Undecanoate Revenue Market Share by Company (2020-2025)
3.3 Global Testosterone Undecanoate Sale Price by Company
3.4 Key Manufacturers Testosterone Undecanoate Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Testosterone Undecanoate Product Location Distribution
  3.4.2 Players Testosterone Undecanoate Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TESTOSTERONE UNDECANOATE BY GEOGRAPHIC REGION

4.1 World Historic Testosterone Undecanoate Market Size by Geographic Region (2020-2025)
  4.1.1 Global Testosterone Undecanoate Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Testosterone Undecanoate Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Testosterone Undecanoate Market Size by Country/Region (2020-2025)
  4.2.1 Global Testosterone Undecanoate Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Testosterone Undecanoate Annual Revenue by Country/Region (2020-2025)
4.3 Americas Testosterone Undecanoate Sales Growth
4.4 APAC Testosterone Undecanoate Sales Growth
4.5 Europe Testosterone Undecanoate Sales Growth
4.6 Middle East & Africa Testosterone Undecanoate Sales Growth

5 AMERICAS

5.1 Americas Testosterone Undecanoate Sales by Country
  5.1.1 Americas Testosterone Undecanoate Sales by Country (2020-2025)
  5.1.2 Americas Testosterone Undecanoate Revenue by Country (2020-2025)
5.2 Americas Testosterone Undecanoate Sales by Type (2020-2025)
5.3 Americas Testosterone Undecanoate Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Testosterone Undecanoate Sales by Region
  6.1.1 APAC Testosterone Undecanoate Sales by Region (2020-2025)
  6.1.2 APAC Testosterone Undecanoate Revenue by Region (2020-2025)
6.2 APAC Testosterone Undecanoate Sales by Type (2020-2025)
6.3 APAC Testosterone Undecanoate Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Testosterone Undecanoate by Country
  7.1.1 Europe Testosterone Undecanoate Sales by Country (2020-2025)
  7.1.2 Europe Testosterone Undecanoate Revenue by Country (2020-2025)
7.2 Europe Testosterone Undecanoate Sales by Type (2020-2025)
7.3 Europe Testosterone Undecanoate Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Testosterone Undecanoate by Country
  8.1.1 Middle East & Africa Testosterone Undecanoate Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Testosterone Undecanoate Revenue by Country (2020-2025)
8.2 Middle East & Africa Testosterone Undecanoate Sales by Type (2020-2025)
8.3 Middle East & Africa Testosterone Undecanoate Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Undecanoate
10.3 Manufacturing Process Analysis of Testosterone Undecanoate
10.4 Industry Chain Structure of Testosterone Undecanoate

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Testosterone Undecanoate Distributors
11.3 Testosterone Undecanoate Customer

12 WORLD FORECAST REVIEW FOR TESTOSTERONE UNDECANOATE BY GEOGRAPHIC REGION

12.1 Global Testosterone Undecanoate Market Size Forecast by Region
  12.1.1 Global Testosterone Undecanoate Forecast by Region (2026-2031)
  12.1.2 Global Testosterone Undecanoate Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Testosterone Undecanoate Forecast by Type (2026-2031)
12.7 Global Testosterone Undecanoate Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Bayer AG
  13.1.1 Bayer AG Company Information
  13.1.2 Bayer AG Testosterone Undecanoate Product Portfolios and Specifications
  13.1.3 Bayer AG Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Bayer AG Main Business Overview
  13.1.5 Bayer AG Latest Developments
13.2 Endo Pharmaceuticals
  13.2.1 Endo Pharmaceuticals Company Information
  13.2.2 Endo Pharmaceuticals Testosterone Undecanoate Product Portfolios and Specifications
  13.2.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Endo Pharmaceuticals Main Business Overview
  13.2.5 Endo Pharmaceuticals Latest Developments
13.3 Merck Sharp & Dohme
  13.3.1 Merck Sharp & Dohme Company Information
  13.3.2 Merck Sharp & Dohme Testosterone Undecanoate Product Portfolios and Specifications
  13.3.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Merck Sharp & Dohme Main Business Overview
  13.3.5 Merck Sharp & Dohme Latest Developments
13.4 Taro Pharmaceutical
  13.4.1 Taro Pharmaceutical Company Information
  13.4.2 Taro Pharmaceutical Testosterone Undecanoate Product Portfolios and Specifications
  13.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Taro Pharmaceutical Main Business Overview
  13.4.5 Taro Pharmaceutical Latest Developments
13.5 Cipla
  13.5.1 Cipla Company Information
  13.5.2 Cipla Testosterone Undecanoate Product Portfolios and Specifications
  13.5.3 Cipla Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Cipla Main Business Overview
  13.5.5 Cipla Latest Developments
13.6 Zhejiang Xianju Pharmaceutical
  13.6.1 Zhejiang Xianju Pharmaceutical Company Information
  13.6.2 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Portfolios and Specifications
  13.6.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Zhejiang Xianju Pharmaceutical Main Business Overview
  13.6.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.7 Zhejiang Medicine Co.
  13.7.1 Zhejiang Medicine Co. Company Information
  13.7.2 Zhejiang Medicine Co. Testosterone Undecanoate Product Portfolios and Specifications
  13.7.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Zhejiang Medicine Co. Main Business Overview
  13.7.5 Zhejiang Medicine Co. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Testosterone Undecanoate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Testosterone Undecanoate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Testosterone Undecanoate Sales by Type (2020-2025) & (K Units)
Table 6. Global Testosterone Undecanoate Sales Market Share by Type (2020-2025)
Table 7. Global Testosterone Undecanoate Revenue by Type (2020-2025) & ($ million)
Table 8. Global Testosterone Undecanoate Revenue Market Share by Type (2020-2025)
Table 9. Global Testosterone Undecanoate Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Testosterone Undecanoate Sale by Application (2020-2025) & (K Units)
Table 11. Global Testosterone Undecanoate Sale Market Share by Application (2020-2025)
Table 12. Global Testosterone Undecanoate Revenue by Application (2020-2025) & ($ million)
Table 13. Global Testosterone Undecanoate Revenue Market Share by Application (2020-2025)
Table 14. Global Testosterone Undecanoate Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Testosterone Undecanoate Sales by Company (2020-2025) & (K Units)
Table 16. Global Testosterone Undecanoate Sales Market Share by Company (2020-2025)
Table 17. Global Testosterone Undecanoate Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Testosterone Undecanoate Revenue Market Share by Company (2020-2025)
Table 19. Global Testosterone Undecanoate Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Testosterone Undecanoate Producing Area Distribution and Sales Area
Table 21. Players Testosterone Undecanoate Products Offered
Table 22. Testosterone Undecanoate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Testosterone Undecanoate Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Testosterone Undecanoate Sales Market Share Geographic Region (2020-2025)
Table 27. Global Testosterone Undecanoate Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Testosterone Undecanoate Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Testosterone Undecanoate Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Testosterone Undecanoate Sales Market Share by Country/Region (2020-2025)
Table 31. Global Testosterone Undecanoate Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Testosterone Undecanoate Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Testosterone Undecanoate Sales by Country (2020-2025) & (K Units)
Table 34. Americas Testosterone Undecanoate Sales Market Share by Country (2020-2025)
Table 35. Americas Testosterone Undecanoate Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Testosterone Undecanoate Sales by Type (2020-2025) & (K Units)
Table 37. Americas Testosterone Undecanoate Sales by Application (2020-2025) & (K Units)
Table 38. APAC Testosterone Undecanoate Sales by Region (2020-2025) & (K Units)
Table 39. APAC Testosterone Undecanoate Sales Market Share by Region (2020-2025)
Table 40. APAC Testosterone Undecanoate Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Testosterone Undecanoate Sales by Type (2020-2025) & (K Units)
Table 42. APAC Testosterone Undecanoate Sales by Application (2020-2025) & (K Units)
Table 43. Europe Testosterone Undecanoate Sales by Country (2020-2025) & (K Units)
Table 44. Europe Testosterone Undecanoate Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Testosterone Undecanoate Sales by Type (2020-2025) & (K Units)
Table 46. Europe Testosterone Undecanoate Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Testosterone Undecanoate Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Testosterone Undecanoate Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Testosterone Undecanoate Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Testosterone Undecanoate Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Testosterone Undecanoate
Table 52. Key Market Challenges & Risks of Testosterone Undecanoate
Table 53. Key Industry Trends of Testosterone Undecanoate
Table 54. Testosterone Undecanoate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Testosterone Undecanoate Distributors List
Table 57. Testosterone Undecanoate Customer List
Table 58. Global Testosterone Undecanoate Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Testosterone Undecanoate Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Testosterone Undecanoate Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Testosterone Undecanoate Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Testosterone Undecanoate Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Testosterone Undecanoate Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Testosterone Undecanoate Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Testosterone Undecanoate Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Testosterone Undecanoate Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Testosterone Undecanoate Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Testosterone Undecanoate Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Testosterone Undecanoate Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Testosterone Undecanoate Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Testosterone Undecanoate Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bayer AG Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer AG Testosterone Undecanoate Product Portfolios and Specifications
Table 74. Bayer AG Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Bayer AG Main Business
Table 76. Bayer AG Latest Developments
Table 77. Endo Pharmaceuticals Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 78. Endo Pharmaceuticals Testosterone Undecanoate Product Portfolios and Specifications
Table 79. Endo Pharmaceuticals Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Endo Pharmaceuticals Main Business
Table 81. Endo Pharmaceuticals Latest Developments
Table 82. Merck Sharp & Dohme Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Sharp & Dohme Testosterone Undecanoate Product Portfolios and Specifications
Table 84. Merck Sharp & Dohme Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Merck Sharp & Dohme Main Business
Table 86. Merck Sharp & Dohme Latest Developments
Table 87. Taro Pharmaceutical Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 88. Taro Pharmaceutical Testosterone Undecanoate Product Portfolios and Specifications
Table 89. Taro Pharmaceutical Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Taro Pharmaceutical Main Business
Table 91. Taro Pharmaceutical Latest Developments
Table 92. Cipla Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Testosterone Undecanoate Product Portfolios and Specifications
Table 94. Cipla Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Cipla Main Business
Table 96. Cipla Latest Developments
Table 97. Zhejiang Xianju Pharmaceutical Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Portfolios and Specifications
Table 99. Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Zhejiang Xianju Pharmaceutical Main Business
Table 101. Zhejiang Xianju Pharmaceutical Latest Developments
Table 102. Zhejiang Medicine Co. Basic Information, Testosterone Undecanoate Manufacturing Base, Sales Area and Its Competitors
Table 103. Zhejiang Medicine Co. Testosterone Undecanoate Product Portfolios and Specifications
Table 104. Zhejiang Medicine Co. Testosterone Undecanoate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Zhejiang Medicine Co. Main Business
Table 106. Zhejiang Medicine Co. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Testosterone Undecanoate
Figure 2. Testosterone Undecanoate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Testosterone Undecanoate Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Testosterone Undecanoate Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Testosterone Undecanoate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Testosterone Undecanoate Sales Market Share by Country/Region (2024)
Figure 10. Testosterone Undecanoate Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral
Figure 13. Global Testosterone Undecanoate Sales Market Share by Type in 2025
Figure 14. Global Testosterone Undecanoate Revenue Market Share by Type (2020-2025)
Figure 15. Testosterone Undecanoate Consumed in Primary Hypogonadism
Figure 16. Global Testosterone Undecanoate Market: Primary Hypogonadism (2020-2025) & (K Units)
Figure 17. Testosterone Undecanoate Consumed in Hypogonadotropic Hypogonadism
Figure 18. Global Testosterone Undecanoate Market: Hypogonadotropic Hypogonadism (2020-2025) & (K Units)
Figure 19. Testosterone Undecanoate Consumed in Late-Onset Hypogonadism
Figure 20. Global Testosterone Undecanoate Market: Late-Onset Hypogonadism (2020-2025) & (K Units)
Figure 21. Global Testosterone Undecanoate Sale Market Share by Application (2024)
Figure 22. Global Testosterone Undecanoate Revenue Market Share by Application in 2025
Figure 23. Testosterone Undecanoate Sales by Company in 2025 (K Units)
Figure 24. Global Testosterone Undecanoate Sales Market Share by Company in 2025
Figure 25. Testosterone Undecanoate Revenue by Company in 2025 ($ millions)
Figure 26. Global Testosterone Undecanoate Revenue Market Share by Company in 2025
Figure 27. Global Testosterone Undecanoate Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Testosterone Undecanoate Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Testosterone Undecanoate Sales 2020-2025 (K Units)
Figure 30. Americas Testosterone Undecanoate Revenue 2020-2025 ($ millions)
Figure 31. APAC Testosterone Undecanoate Sales 2020-2025 (K Units)
Figure 32. APAC Testosterone Undecanoate Revenue 2020-2025 ($ millions)
Figure 33. Europe Testosterone Undecanoate Sales 2020-2025 (K Units)
Figure 34. Europe Testosterone Undecanoate Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Testosterone Undecanoate Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Testosterone Undecanoate Revenue 2020-2025 ($ millions)
Figure 37. Americas Testosterone Undecanoate Sales Market Share by Country in 2025
Figure 38. Americas Testosterone Undecanoate Revenue Market Share by Country (2020-2025)
Figure 39. Americas Testosterone Undecanoate Sales Market Share by Type (2020-2025)
Figure 40. Americas Testosterone Undecanoate Sales Market Share by Application (2020-2025)
Figure 41. United States Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Testosterone Undecanoate Sales Market Share by Region in 2025
Figure 46. APAC Testosterone Undecanoate Revenue Market Share by Region (2020-2025)
Figure 47. APAC Testosterone Undecanoate Sales Market Share by Type (2020-2025)
Figure 48. APAC Testosterone Undecanoate Sales Market Share by Application (2020-2025)
Figure 49. China Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 53. India Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Testosterone Undecanoate Sales Market Share by Country in 2025
Figure 57. Europe Testosterone Undecanoate Revenue Market Share by Country (2020-2025)
Figure 58. Europe Testosterone Undecanoate Sales Market Share by Type (2020-2025)
Figure 59. Europe Testosterone Undecanoate Sales Market Share by Application (2020-2025)
Figure 60. Germany Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 61. France Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Testosterone Undecanoate Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Testosterone Undecanoate Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Testosterone Undecanoate Sales Market Share by Application (2020-2025)
Figure 68. Egypt Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Testosterone Undecanoate Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Testosterone Undecanoate in 2025
Figure 74. Manufacturing Process Analysis of Testosterone Undecanoate
Figure 75. Industry Chain Structure of Testosterone Undecanoate
Figure 76. Channels of Distribution
Figure 77. Global Testosterone Undecanoate Sales Market Forecast by Region (2026-2031)
Figure 78. Global Testosterone Undecanoate Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Testosterone Undecanoate Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Testosterone Undecanoate Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Testosterone Undecanoate Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Testosterone Undecanoate Revenue Market Share Forecast by Application (2026-2031)